Viral Vector Core TubeWriter 300

Background
The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), Office of Acquisitions intends to negotiate and award a contract without providing for full and open competition to TubeWriter, LLC, located at 6500 River Place Blvd., Suite 100, Austin, TX 78730.

The Viral Vector Core Facility has identified a unique requirement for a high-speed, direct-to-labware printing system that meets stringent operational needs, including solvent-resistant inks and compatibility with cold storage conditions. After a thorough market analysis and technical evaluation, it has been determined that TubeWriter, LLC is the sole source capable of providing equipment that satisfies all required specifications.

The system proposed by TubeWriter, LLC is the only commercially available solution that offers the necessary speed of operation, direct printing onto laboratory consumables, and the use of solvent-resistant inks that maintain legibility and adhesion under extreme storage temperatures. These capabilities are critical to the workflows and regulatory compliance of the Viral Vector Core Facility.

Work Details
The contract will involve the procurement of the Viral Vector Core TubeWriter 300. This system must meet specific requirements such as high-speed operation, direct printing onto labware, and compatibility with solvent-resistant inks suitable for cold storage conditions.

The exact specifications include:
- High-speed direct-to-labware printing
- Use of solvent-resistant inks
- Capability to maintain legibility and adhesion under extreme storage temperatures.

Place of Performance
Bethesda, Maryland